Share Name Share Symbol Market Type Share ISIN Share Description
Bioventix LSE:BVXP London Ordinary Share GB00B4QVDF07 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +5.00p +0.23% 2,200.00p 2,150.00p 2,250.00p - - - 0 07:33:23
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 5.5 4.2 69.2 31.8 112.17

Bioventix Share Discussion Threads

Showing 576 to 599 of 600 messages
Chat Pages: 24  23  22  21  20  19  18  17  16  15  14  13  Older
DateSubjectAuthorDiscuss
23/8/2017
07:56
I sold my holding yesterday. The shares have had a fantastic run but I was starting to get twitchy about a price sales ratio of 18 and PE ratio in the high 20s. I may regret this when the next results are out but for now I will continue to monitor from the sidelines.
impvesta
23/8/2017
07:41
Amati Global Investors have issued their August newsletter, and in it there's a spotlight on BVXP : Http://amatiglobal.com/documents/Newsletter/Amati_Newsletter_Issue_7.pdf (copied from a post elsewhere by rivaldo)
janeann
23/8/2017
05:32
It all depends on the Siemens related troponin progress and transition from loss of revenue from one source to the new troponin source. If there is good news BVXP should respond well. If ANY disappointment/delay on the update to the last news, when the company were not even aware Siemens had started using it (a bit of a concern), then we can expect a smack down and possible buying opportunity.
lauders
23/8/2017
05:09
Last year's numbers benefited from the post brexit collapse in the GBP which prompted the trading update as brokers' forecasts did not reflect this upside. It was the first trading update Bioventix had given since joining AIM. I'm not expecting another one this time around although I hope we will see a small beat on the 77p EPS forecast when the results are announced on October 16th.
boros10
22/8/2017
12:29
I was assuming the same - I'll email the company
panic investor
22/8/2017
10:08
whilstev - if that were true, then we could assume that results this year are not ahead of expectations. That's why trading updates tend to be regular occurences, otherwise people assume the worst when they don't appear. They issued an update on 4th September 2015, and 22nd August last year. I'm hoping they put one out this year. StepOne
stepone68
22/8/2017
09:28
There is no update planned. Last year was only because results were ahead of expectations.
whilstev
21/8/2017
09:50
Any confirmation of the update anywhere ?
panic investor
18/8/2017
15:47
Good fundamentals
luckymouse
14/8/2017
09:18
Good timing Panic Investor! The update must be a good one or there would be no reason for such strength before their release? Either that or some are just gambling they will be good!
lauders
11/8/2017
20:53
Hopefully a trading update in the next 2 weeks
valustar1
11/8/2017
13:09
Possibly some "hot money" switching into a safer home too? Wish I had topped up lower down myself now!
lauders
11/8/2017
11:50
Spotted that too - increased here yesterday myself
panic investor
11/8/2017
11:48
There was a small write up in the Evening Standard following the UK Buffettology fund increasing its stake. It described Bioventix as "bombproof". It's probably caused the latest little bit of excitement.
ragehammer
11/8/2017
11:42
Bit of excitement in the share price for the first time in a few months. Some interest ahead of a trading update this month?
stepone68
01/8/2017
14:45
Http://www.alzforum.org/news/conference-coverage/finally-blood-test-alzheimers Another article on the recently revealed Bateman beta amyloid blood test for Alzheimers. More positive comments on the significance of, need for and usage of a blood based test. Not clear whether this Bateman test can be adapted to run on the workhorse lab diagnostic machines that a Pre Diagnostics/Bioventix test would target.
gsbmba99
28/7/2017
12:35
gsbmba99, thank you - looks like i've got research work to do. Much more interesting than watching sp's :-)
piedro
28/7/2017
07:49
Sharw, I've edited the post and hopefully the links work. Piedro, the links I included from the Pre Diagnostics website are full text research papers published by, amongst others, Tormod Fladby whose research forms the basis for Pre Diagnostics' work. There are more at the Pre Diagnostics website (>New invention >R&D History) Bioventix wasn't involved in the original research but has since announced a collaboration ( Https://investegate.co.uk/bioventix-plc--bvxp-/prn/collaboration-with-pre-diagnostics-as/20160531070000PD6BB/ )
gsbmba99
28/7/2017
00:17
gsbmba99 - Your links do not work because you add parentheses on both ends without a space. For links to work there must be a space at both ends. Piedro - delete those additions and they will work.
sharw
27/7/2017
22:25
gsbmba99, Thank you for postings though I have not been able to open the links. Alzheimer's testings are certainly a topic to put off most but I have found a couple of sites that explain the situation in simple terms ... Beta Amyloid Protein, Plaque, and Alzheimer's hTTps://www.verywell.com/beta-amyloid-protein-plaque-and-alzheimers-98053 Quest for biomarkers (approx. 17 min.) hTTp://www.alz.org/research/video/video_pages/quest_for_biomarkers.html ... which brings me to your question before I dive into further research: "What about Pre Diagnostics/Bioventix?" and can you point me to a reference where Bioventix is said to be involved in such research? TIA.
piedro
27/7/2017
20:11
The Bateman test revealed recently measures the ratio of beta amyloid 1-42 to beta amyloid 1-40 ( Https://medicine.wustl.edu/news/blood-test-ids-key-alzheimers-marker-brain/ ). In a study of 41 people it was 89% accurate in being able to characterise people as beta amyloid positive or negative. What about Pre Diagnostics/Bioventix? The beta amyloid build up is caused when it begins to naturally degrade at a slower rate causing the formation of amyloid plaques. The Pre-diagnostics research ( Http://pre-diagnostics.com/wordpress/wp-content/uploads/2015/10/Identification-of-peptide-products-from-enzymatic-degradation-Biochimie-105-2014216-220.pdf ) ( Http://pre-diagnostics.com/wordpress/wp-content/uploads/2015/10/Identification-of-amyloid-beta-mid-domain-fragments-in-human-cerebrospinal-fluid-Biochimie-2015.pdf )focuses on the mid range of beta amyloid where they think the natural degradation is impacted. So, it would seem they are seeking to identify diseased or abnormal beta amyloid incapable of being naturally degraded in the bloodstream by developing an antibody to bind to a different part of beta amyloid than existing antibodies.
gsbmba99
27/7/2017
19:53
Did a bit more reading on beta amyloid. Interesting chart here ( Http://www.alzforum.org/alzbiomarker ). If you click only AD vs Ctrl (Plasma/Serum), the chart, if I've interpreted it correctly, suggests that no single biomarker is statistically significant in the Alzheimers Disease (AD) cohort vs the control group when measured in blood. You can change the settings to look at AD vs Ctrl in CSF and there are multiple biomarkers that are statistically significant. This is consistent with the beta amyloid theory that excess amounts are deposited in the brain. Any test simply looking for the amount of beta amyloid (or Tau) in blood is unlikely to be useful because the amount of beta amyloid in the blood stream isn't different between those with AD and those without.
gsbmba99
22/7/2017
10:42
Slightly dated article looking at developments in automated CSF assays (Http://www.alzforum.org/news/conference-coverage/are-csf-assays-finally-ready-prime-time). According to the article, Roche, Fujirebio and Euroimmun are introducing automated, CE marked CSF assays for beta amyloid 1-42 (and others) in 2017. Fujirebio is in the market in Europe already, Roche supposedly June and Euroimmun (now owned by Perkin-Elmer) later in the year. Euroimmun are using an antibody developed by Adx Neurosciences (Http://www.adxneurosciences.com/en/pipeline) who also appear to be well advanced with a blood test. Fujirebio looks to be using an antibody from Eli Lilly ("a license for the use of amyloid beta monoclonal antibodies contained in this product under patents US 6114133, US7811769, and EP 0792458 has been obtained from Eli Lilly" from Https://www.fujirebio-europe.com/products-services/product-browser/innotestr-v-amyloid1-42). Roche unclear. Article also notes issues with generating consistent results.
gsbmba99
21/7/2017
07:53
The Alzheimers Association International Conference just concluded in London (Https://www.alz.org/aaic/releases_2017/AAIC17-Wed-briefing-Developing-Topcis.pdf). Go to Blood Biomarker for Amyloid Plaques. Dr. Bateman: “We’re excited because the results also suggest that blood-derived amyloid-beta may be useful as a rapid and inexpensive screening test for brain amyloidosis, and may be able to identify people who are at higher risk of Alzheimer’s disease very early in the process.” ... "Having a simple and inexpensive blood test for screening is likely to greatly accelerate clinical trials to find Alzheimer’s drugs. And, it could facilitate widespread treatment when effective anti-amyloid therapeutics are developed,” Bateman added. Not directly related to BVXP as I think it's a different test but useful in the ongoing effort to establish clinical usefulness of blood based beta amyloid testing.
gsbmba99
Chat Pages: 24  23  22  21  20  19  18  17  16  15  14  13  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20170824 07:00:16